Ategenos Pharmaceuticals
PrivateCompany Overview
Ategenos Pharmaceuticals is a PharmaTech company that develops the SmartPatch platform, an advanced transdermal system designed to provide sustained drug delivery with real-time medication adherence monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Health IoT, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ategenos Pharmaceuticals Comparables
Compare Ategenos Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remagine Labs | 80% | |
| Medicsen | 74% | |
| PillSafe Technologies | 69% |
Ategenos Pharmaceuticals Funding Rounds
Historical fundraising activity
Ategenos Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ategenos Pharmaceuticals's valuation, stock price, and market status.
Is Ategenos Pharmaceuticals a public or private company?
Ategenos Pharmaceuticals is a private company.
What is the current stock price of Ategenos Pharmaceuticals?
Ategenos Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Ategenos Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ategenos Pharmaceuticals worth (valuation)?
Valuation information for Ategenos Pharmaceuticals is not publicly available.
Can I buy Ategenos Pharmaceuticals stock?
Ategenos Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ategenos Pharmaceuticals's last funding round?
Funding round information for Ategenos Pharmaceuticals is not publicly available.
Who are the main investors in Ategenos Pharmaceuticals?
Investor information for Ategenos Pharmaceuticals is not publicly disclosed.
Will Ategenos Pharmaceuticals IPO soon?
No public IPO plans have been announced for Ategenos Pharmaceuticals.
How can I track Ategenos Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Ategenos Pharmaceuticals's shares on secondary markets.